Gunnar F. Kaufmann

Chief Scientific Officer, Oncternal Therapeutics, Inc.

Companies

Oncternal Therapeutics, Inc.Chief Scientific Officer Sep 9, 2019 to Jun 14, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oncternal Therapeutics, Inc.94,726 shares²Jun 14, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 14, 2023Bought 3,000 shares at $0.36 of Oncternal Therapeutics, Inc.²
Jun 12, 2023Bought 25,000 shares at $0.35 of Oncternal Therapeutics, Inc.²
Jan 3, 2023Shares withheld for tax 6,266 shares at $1.02 of Oncternal Therapeutics, Inc.³
Jul 28, 2022Granted 43,125 shares of Oncternal Therapeutics, Inc.⁴
Jan 3, 2022Granted 29,867 shares of Oncternal Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncternal Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGAROncternal Therapeutics, Inc. shares after the filing of Jun 14, 2023
3
SEC EDGARForm 4 filed Jan 5, 2023
4
SEC EDGARForm 4 filed Aug 1, 2022
5
SEC EDGARForm 4 filed Jan 5, 2022